Contact Us

SEC Filings

Investor Contacts

Andrea N. Flynn, Ph.D.
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717

SEC Filings

Filing date	Form	Description	Filing Group	View
May 31, 2007	FWP	FWP	Other	View HTML 0001193125-07-126478.pdf 0001193125-07-126478.rtf 0001193125-07-126478.xls
Mar 06, 2012	FWP	FWP	Other	View HTML 0001193125-12-097398.pdf 0001193125-12-097398.rtf 0001193125-12-097398.xls
Jul 16, 2008	FWP	FWP	Other	View HTML 0001193125-08-151478.pdf 0001193125-08-151478.rtf 0001193125-08-151478.xls
Mar 05, 2013	FWP	FWP	Other	View HTML 0001193125-13-090091.pdf 0001193125-13-090091.rtf 0001193125-13-090091.xls
Dec 11, 2009	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	Registration Statements	View HTML 0001193125-09-251568.pdf 0001193125-09-251568.rtf 0001193125-09-251568.xls
Nov 23, 2009	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	Registration Statements	View HTML 0001193125-09-240429.pdf 0001193125-09-240429.rtf 0001193125-09-240429.xls
May 10, 2010	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	Registration Statements	View HTML 0001193125-10-114733.pdf 0001193125-10-114733.rtf 0001193125-10-114733.xls
Jul 16, 2008	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	Registration Statements	View HTML 0001193125-08-152094.pdf 0001193125-08-152094.rtf 0001193125-08-152094.xls
May 12, 2010	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	Registration Statements	View HTML 0001193125-10-116733.pdf 0001193125-10-116733.rtf 0001193125-10-116733.xls
Jan 19, 2012	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	Registration Statements	View HTML 0001193125-12-016275.pdf 0001193125-12-016275.rtf 0001193125-12-016275.xls

Data provided by Kaleidoscope.